North America Urology Devices Market Outlook, 2030

The market for urology devices in North America has advanced to become one of the most developed segments in healthcare technology. The use of urology devices started with basic catheters and cystoscopes in hospitals and has progressed to include sophisticated lithotripsy systems, endoscopic stents, and robotic surgical devices. These tools have a broad range of functions and applications they facilitate the diagnosis and treatment of issues related to the urinary tract, such as kidney stones, benign prostatic hyperplasia BPH, urinary incontinence, and bladder cancers. Major users of these devices include hospitals, outpatient surgical centers, and increasingly home-care environments, indicating a trend towards outpatient services and less invasive treatment options. In technical terms, urology devices refer to medical instruments designed for the urinary and male reproductive systems; this category includes laser lithotripters for breaking down stones, disposable digital ureteroscopes, robotic arms for prostate surgery, and smart catheters for managing incontinence. These devices tackle practical issues, including the rapid removal of kidney stones, reducing recovery time after prostate operations, or enhancing the quality of life for those suffering from urinary incontinence. Their efficiency is evident through decreased recovery durations, lower rates of complications, and improved patient results when compared to traditional open surgeries. In terms of research and development, companies like Boston Scientific Corporation, Medtronic plc, and Stryker Corporation are making significant investments in AI-driven imaging, robotics, single-use endoscopes equipped with sensors, and platforms for remote monitoring. Regulatory standards, such as the U.S. Food & Drug Administration FDA clearance processes and ISO 13485 manufacturing certification, guarantee that new devices uphold safety, effectiveness, and reliability benchmarks. These certifications enhance confidence among healthcare providers and buyers, shorten the time it takes to bring products to market, and ensure that devices function reliably in real-world clinical environments in North America.

According to the research report, "" North America Urology Devices Market Outlook, 2030,"" published by Bonafide Research, the North America Urology Devices market was valued at USD 13.64 Billion in 2024. In North America, the presence of highly advanced hospital systems, state-of-the-art surgical facilities, and a rise in outpatient procedures has created an environment conducive to the adoption of innovative urology equipment. Recent changes in the region are indicative of this advancement prominent hospitals are incorporating digital systems alongside robotic surgery technologies for instance, console-based robotic prostate surgery or nephrolithotomy machines combined with AI-powered imaging solutions; minimally invasive instruments including single-use digital ureteroscopes and high-efficiency laser lithotripsy equipment are becoming the standard treatment for kidney conditions and benign prostatic hyperplasia BPH. Key industry players include Boston Scientific Corporation, which provides a comprehensive urology product range featuring catheters, scopes, and tools for stone management; Coloplast A/S, specializing in urinary continence and lower urinary tract devices for both hospitals and home care; and Cook Medical, which focuses on developing minimally invasive urology devices and access systems. Each company targets a unique market segment hospital, outpatient surgical centers, and home care enabling them to meet diverse regional needs for diagnostics, surgical procedures, and post-surgery care. increasing elderly population in the area, along with a higher prevalence of prostate enlargement, urinary issues, and kidney stones, is driving demand for urology devices.

Market Drivers

• Increasing Incidence of Urological Conditions and Aging DemographicsIn North America, there is a notable rise in urological issues, including benign prostatic hyperplasia BPH, urinary incontinence, bladder cancer, and kidney stones. This surge is primarily attributed to an aging population and lifestyle influences, such as obesity and diabetes. The U.S. and Canada rank among the highest ly for prostate and kidney disease occurrences, which drives up the demand for diagnostic and treatment devices. With the elderly population expected to surpass 80 million by 2030 in the U.S., the necessity for less invasive urological procedures has grown significantly.
• Innovations in Technology and Robust Healthcare SystemsThe advanced technology landscape within North America's healthcare framework promotes swift innovation and the adoption of advanced urology systems. Robotic-assisted surgical platforms like da Vinci and Hugo RAS as well as AI-enhanced imaging technologies are being progressively incorporated into operating theaters, leading to improved surgical accuracy and reduced patient trauma. The region's strong digital infrastructure facilitates data-informed decision-making and clinical integration among hospitals.

Market Challenges

• Elevated Equipment Expenses and Budget LimitationsDespite advancements in technology, expenses remain a significant challenge across the North American urology device sector. Smaller community hospitals and independent ASCs encounter financial constraints in acquiring and maintaining such costly equipment. Increasing maintenance fees, costs of consumables, and the need for staff training exacerbate these challenges. Inconsistent reimbursement policies for certain minimally invasive or laser-assisted methods hinder broader acceptance.
• Strict Regulatory Standards and Sterilization RequirementsThe U.S. FDA's 510k and PMA processes are critical for ensuring safety but notably prolong the timeline for new devices to reach the market. Adhering to ISO 13485 quality requirements and the Unique Device Identification UDI system necessitates thorough documentation, rigorous testing, and ongoing traceability. Reusable tools like cystoscopes encounter difficulties in proving sterilization effectiveness due to increasingly stringent infection-control audits following incidents of hospital-acquired infections.

Market Trends

• Movement Towards Outpatient and Ambulatory Urology CareA significant trend in the North American sector is the shift of urological surgeries from hospitals to ambulatory surgical centers ASCs. Operations such as lithotripsy, TURP, and cystoscopy are increasingly carried out in outpatient environments due to innovations in compact and portable technology. This transition is in line with efforts to reduce healthcare costs and align with patient desires for same-day recovery. Manufacturers are adapting by creating modular, easy-to-set-up devices and single-use tools that minimize sterilization requirements.
• Merging of AI, Digital Health, and Tele-UrologyArtificial intelligence and digital integration are transforming practices in North American urology. AI-enhanced imaging tools improve the early identification of kidney stones and prostate abnormalities, while predictive analytics aid in clinical judgment and post-surgery planning. Tele-urology services, accelerated by the pandemic, are broadening specialist access to rural communities and enhancing care continuity. Hospitals and device manufacturers are investigating data-sharing networks for real-time oversight of stent health, catheter functionality, and infection likelihood.

The accessories catheters, stents, lubricants/gels, and other disposable items are the most significant and rapidly expanding segment in the urology devices market in North America.

The accessories catheters, stents, lubricants/gels, and other disposable items growth is due to its capacity to facilitate high volumes of procedures in various environments while providing affordable, single-use, or short-term solutions that adhere to standards for infection control, shifts towards outpatient care motivated by reimbursement, and increasing rates of chronic urological conditions. Delving deeper, the developed healthcare system in North America, favorable reimbursement policies, and high prevalence of urological issues lead to a constant need for accessories. Market research indicates that accessories comprise the largest market share based on product type, thanks to the rising use of catheters, dilators, and other disposable items in medical settings focusing on urology. For instance, catheterization whether intermittent or indwelling is a standard practice in managing conditions like benign prostatic hyperplasia BPH, urinary incontinence, spinal cord injuries, or postoperative care, resulting in the frequent need for catheters and associated consumables. Hospitals and outpatient surgical centers are increasingly opting for single-use or disposable accessories to minimize infection risks and streamline logistics. The emphasis of the U.S. healthcare system on lowering catheter-associated urinary tract infections CAUTIs creates a strong demand for improved catheter products. Stents ureteral and urethral and accompanying gels or lubricants follow a similar trend, serving as necessary tools in various urological procedures including stone extraction, stent installation, and catheterization, thereby providing a recurring revenue opportunity. Furthermore, as a growing number of urology services transition from inpatient facilities to outpatient clinics or home care, accessories are becoming essential due to their lower costs, ease of use, and lack of the significant financial investment needed for robotic devices or endoscopes. This transition is observable in the North American market, where home-based urology services and minimally invasive procedures are becoming more popular.

The main factor that makes the by Application, Urolithiasis stone disease section the largest segment in the North American urology-devices market is that the rates of kidney and urinary tract stones are much more common in the U.S. and Canada compared to several other areas. This leads to a high number of procedures and a well-established base for devices aimed at managing stones.

In North America, the challenge posed by urolithiasis has been rising consistently, with about 13% of individuals in this area affected. This increased figure results in a significant number of patients needing both diagnostic and treatment options for stone disease. Urolithiasis is often acute and recurring, frequently requiring procedures such as ureteroscopy, laser lithotripsy, extracorporeal shock wave lithotripsy ESWL, percutaneous nephrolithotomy, and stent insertions. Given the high rates of stone formation, recurrence, and necessary interventions, there is considerable demand for endoscopic instruments, lithotripters, stents, and tools for stone retrieval. The region’s sophisticated healthcare system, favorable reimbursement policies, and strong acceptance of minimally invasive technologies increase the importance of stone-management devices. When hospitals and outpatient surgical facilities invest in and utilize advanced devices for treating stones, the number of procedures performed increases, consequently boosting the market for these devices. Furthermore, stone recurrence rates which can reach as high as 50% within 5 to 7 years according to some studies lead to repeat procedures, making the stone-management segment not only extensive but also consistently in demand. The combination of high urolithiasis rates in North America, the continuing need for therapeutic measures, the use of advanced devices, and solid healthcare support and reimbursement results in the stone disease application becoming the largest and fastest-expanding segment in the North American urology-devices market.

Hospitals and clinics represent the most significant end-use category in the North American market for urology devices because these institutions provide extensive infrastructure alongside modern diagnostic and surgical solutions for urological issues, leading to increased patient visits and greater usage of devices.

North America stands at the forefront of the urology devices sector, mainly because hospitals and clinics serve as primary locations for urological treatment. These healthcare facilities are outfitted with advanced technology and skilled staff able to identify and manage a diverse range of urological ailments, such as kidney stones, benign prostatic hyperplasia BPH, urinary incontinence, and prostate cancer. Patients tend to choose hospitals and clinics due to their higher standards of quality and safety, the presence of specialized tools like cystoscopes, ureteroscopes, and urology lasers, as well as the options for both invasive and non-invasive therapies. The increase in chronic kidney diseases and age-related urological conditions has led to a significant rise in patient visits, which boosts the ongoing need for sophisticated urology devices. Favorable healthcare reimbursements and insurance plans in the area allow complex and minimally invasive treatments to be more affordable for individuals, thus increasing the number of procedures performed and the demand for innovative devices. Furthermore, hospitals and clinics offer a wider range of applications for urological devices from diagnosis and monitoring to active treatment and post-care positioning them as vital centers for market growth. Ongoing technological advancements in urology, such as smart catheters and robotic-assisted surgery, are being adopted more swiftly in hospital environments, reinforcing their leading position in the market. Ambulatory surgical centers ASCs and clinics are also becoming more prominent as they provide enhanced cost-effectiveness, specialized facilities, and streamlined billing processes, supporting the traditional role of hospitals and contributing to the expansion of the device market. Therefore, the combination of high patient volumes, access to state-of-the-art technology, trained professionals, and supportive healthcare policies makes hospitals and clinics the foremost end-use category for urology devices in North America.

The North America urology devices market is predominantly led by the US due to its sophisticated healthcare system, a high incidence of urological conditions, and swift acceptance of new technologies.

The US is recognized as the principal market for urology devices within North America, mainly due to its strong healthcare foundation that allows extensive access to advanced diagnostics, treatments, and surgical options. The nation is experiencing a significant and escalating prevalence of chronic kidney issues, prostate cancer, urinary incontinence, and benign prostatic hyperplasia BPH, which necessitate various complex urology devices. Moreover, the growing elderly population in the US, who are more vulnerable to age-related urological health problems, increases the demand for continuous medical support, routine screenings, and surgical care. Policies from the government encourage research and healthcare investment, which in turn facilitates the quick development of devices and their rapid introduction into the market through methods like expedited FDA approvals. Comprehensive insurance policies and well-structured reimbursement frameworks also make treatments and devices more accessible and economical for a large portion of the population. Leading medical tech firms, many based in the US, are at the forefront of advancements in minimally invasive, home care, and robotic-assisted urology techniques, constantly enhancing the quality of patient care and utilization of modern devices. The incorporation of innovations such as AI in diagnostics, Internet of Things for remote monitoring, and intelligent surgical platforms bolsters the US's dominant position. Continuous public education efforts and enhanced patient screening contribute to earlier diagnosis and treatment of urological illnesses, increasing the need for diagnostic tools. This comprehensive environment characterized by high disease rates, technological progress, a skilled labor force, and effective health policies ensures that the US remains the leader in the North American urology devices sector.


***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation. Show more